• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA MALAT1 在癌症中的诊断、预后和治疗意义。

Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer.

机构信息

Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi 221005, India.

出版信息

Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188502. doi: 10.1016/j.bbcan.2021.188502. Epub 2021 Jan 8.

DOI:10.1016/j.bbcan.2021.188502
PMID:33428963
Abstract

Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) is a widely studied lncRNA in cancer. Although dispensable for normal physiology, MALAT1 is important for cancer-related pathways regulation. It is localized in the nuclear speckles periphery along with centrally located pre-RNA splicing factors. MALAT1 associated cancer signaling pathways include MAPK/ERK, PI3K/AKT, β-catenin/Wnt, Hippo, VEGF, YAP, etc. Molecular tools such as immunoprecipitation, RNA pull-down, reporter assay, Northern blotting, microarray, and q-RT-PCR has been used to elucidate MALAT1's function in cancer pathogenesis. MALAT1 can regulate multiple steps in the development of tumours. The diagnostic and prognostic significance of MALAT1 has been demonstrated in cancers of the breast, cervix, colorectum, gallbladder, lung, ovary, pancreas, prostate, glioma, hepatocellular carcinoma, and multiple myeloma. MALAT1 has also emerged as a novel therapeutic target for solid as well as hematological malignancies. In experimental models, siRNA and antisense oligonucleotide (ASO) based strategy has been used for targeting MALAT1. The lncRNA has also been targeted for the chemosensitization and radiosensitization of cancer cells. However, most studies have been performed in preclinical models. How the cross-talk of MALAT1 with other signaling pathways affect cancer pathogenesis is the focus of this article. The diagnostic, prognostic, and therapeutic significance of MALAT1 in multiple cancer types are discussed.

摘要

转移相关肺腺癌转录物 1(MALAT1)是癌症中研究广泛的 lncRNA。尽管 MALAT1 对于正常生理过程不是必需的,但它对于癌症相关途径的调节很重要。它位于核斑点的外周,与中央定位的前 RNA 剪接因子一起。MALAT1 相关的癌症信号通路包括 MAPK/ERK、PI3K/AKT、β-catenin/Wnt、Hippo、VEGF、YAP 等。免疫沉淀、RNA 下拉、报告基因检测、Northern 印迹、微阵列和 q-RT-PCR 等分子工具已被用于阐明 MALAT1 在癌症发病机制中的作用。MALAT1 可以调节肿瘤发生的多个步骤。MALAT1 的诊断和预后意义已在乳腺癌、宫颈癌、结直肠癌、胆囊癌、肺癌、卵巢癌、胰腺癌、前列腺癌、神经胶质瘤、肝细胞癌和多发性骨髓瘤等癌症中得到证实。MALAT1 也已成为实体瘤和血液恶性肿瘤的新治疗靶点。在实验模型中,已使用 siRNA 和反义寡核苷酸(ASO)策略来靶向 MALAT1。该 lncRNA 还被用于癌症细胞的化疗增敏和放疗增敏。然而,大多数研究都是在临床前模型中进行的。MALAT1 与其他信号通路的相互作用如何影响癌症发病机制是本文的重点。讨论了 MALAT1 在多种癌症类型中的诊断、预后和治疗意义。

相似文献

1
Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer.长链非编码 RNA MALAT1 在癌症中的诊断、预后和治疗意义。
Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188502. doi: 10.1016/j.bbcan.2021.188502. Epub 2021 Jan 8.
2
Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.转移相关肺腺癌转录本 1:在致癌作用中的表达模式和功能的最新研究进展。
Exp Mol Pathol. 2020 Feb;112:104330. doi: 10.1016/j.yexmp.2019.104330. Epub 2019 Nov 9.
3
Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.长链非编码RNA肺腺癌转移相关转录本1(MALAT1)与雌激素受体相互作用,并预示着乳腺癌患者的不良生存结局。
Oncotarget. 2016 Jun 21;7(25):37957-37965. doi: 10.18632/oncotarget.9364.
4
Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.长链非编码RNA MALAT1的上调与透明细胞肾细胞癌的肿瘤进展及不良预后相关。
Tumour Biol. 2015 Apr;36(4):2947-55. doi: 10.1007/s13277-014-2925-6. Epub 2014 Dec 6.
5
Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.长链非编码RNA转移相关肺腺癌转录本1通过miR-202调控Gli2的表达以促进胃癌进展。
Biomed Pharmacother. 2017 Jan;85:264-271. doi: 10.1016/j.biopha.2016.11.014. Epub 2016 Nov 22.
6
Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.lncRNA-MALAT1 与 miR-124 的相互作用通过 PI3K/Akt 信号通路调节 HBx 诱导的 HepG2 肿瘤干细胞特性。
J Cell Biochem. 2019 Mar;120(3):2908-2918. doi: 10.1002/jcb.26823. Epub 2018 Nov 30.
7
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.长链非编码RNA MALAT1作为一种竞争性内源性RNA,通过在透明细胞肾癌中吸附miR-200s来调节ZEB2的表达。
Oncotarget. 2015 Nov 10;6(35):38005-15. doi: 10.18632/oncotarget.5357.
8
New Insights into Long Non-Coding RNA in Cancer and Metastasis.长链非编码RNA在癌症与转移中的新见解
Cancers (Basel). 2019 Feb 13;11(2):216. doi: 10.3390/cancers11020216.
9
Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer.一种新鉴定的MALAT1可变剪接转录本在乳腺癌中的预后价值。
Br J Cancer. 2016 Jun 14;114(12):1395-404. doi: 10.1038/bjc.2016.123. Epub 2016 May 12.
10
Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.用双重 MEK/Aurora 激酶抑制剂 BI-847325 对间变性甲状腺癌进行 MALAT1 介导的细胞周期和凋亡基因的转录水平调控。
Daru. 2019 Jun;27(1):1-7. doi: 10.1007/s40199-018-0231-3. Epub 2019 May 10.

引用本文的文献

1
Lack of association between rs591291 and rs3200401 polymorphisms and venous malformation risk in the Chinese pediatric population.在中国儿科人群中,rs591291和rs3200401基因多态性与静脉畸形风险之间不存在关联。
Biochem Biophys Rep. 2025 Aug 15;43:102209. doi: 10.1016/j.bbrep.2025.102209. eCollection 2025 Sep.
2
Approaches for Identifying LncRNA-Associated Proteins for Therapeutic Targets and Cancer Biomarker Discovery.用于鉴定lncRNA相关蛋白以发现治疗靶点和癌症生物标志物的方法。
Targets (Basel). 2025 Sep;3(3). doi: 10.3390/targets3030027. Epub 2025 Aug 11.
3
promotes malignancy of HBV-related hepatocellular carcinoma by regulating IGF2BP3-mediated nuclear-cytoplasmic shuttling.
通过调节IGF2BP3介导的核质穿梭促进乙肝病毒相关肝细胞癌的恶性发展。
Int J Biol Sci. 2025 Jul 28;21(11):4942-4960. doi: 10.7150/ijbs.112133. eCollection 2025.
4
The diagnostic and prognostic value of LncRNA FAM3D-AS1 expression in nasopharyngeal carcinoma and its effect on tumor progression and cisplatin resistance.长链非编码RNA FAM3D-AS1表达在鼻咽癌中的诊断和预后价值及其对肿瘤进展和顺铂耐药的影响
Hereditas. 2025 Aug 26;162(1):171. doi: 10.1186/s41065-025-00526-0.
5
Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms.表观遗传机制对肺癌顺铂耐药性的调控
Clin Epigenetics. 2025 Aug 24;17(1):145. doi: 10.1186/s13148-025-01961-6.
6
Biomarkers via liquid biopsy for distinguishing malignant from benign pulmonary ground-glass nodule.通过液体活检区分肺磨玻璃结节良恶性的生物标志物
iScience. 2025 Jul 16;28(9):113128. doi: 10.1016/j.isci.2025.113128. eCollection 2025 Sep 19.
7
Bioinformatics-based prognostic value and functional validation of PTK6 in cutaneous melanoma.基于生物信息学的PTK6在皮肤黑色素瘤中的预后价值及功能验证
Front Oncol. 2025 Jul 30;15:1555302. doi: 10.3389/fonc.2025.1555302. eCollection 2025.
8
Nuclear ribonucleoprotein condensates as platforms for gene expression regulation.核糖核蛋白凝聚物作为基因表达调控的平台。
Genes Genomics. 2025 Sep;47(9):935-951. doi: 10.1007/s13258-025-01661-8. Epub 2025 Aug 4.
9
The roles of lncMALAT1 in coronary artery disease regulation and therapeutic perspective: A systematic review.lncMALAT1在冠状动脉疾病调控中的作用及治疗前景:一项系统综述
iScience. 2025 Jun 20;28(7):112945. doi: 10.1016/j.isci.2025.112945. eCollection 2025 Jul 18.
10
Dual role of lncRNA OTUD6B-AS1 in immune evasion and ferroptosis resistance: A prognostic and therapeutic biomarker in breast cancer.长链非编码RNA OTUD6B-AS1在免疫逃逸和铁死亡抗性中的双重作用:乳腺癌的一种预后和治疗生物标志物
Noncoding RNA Res. 2025 Jun 17;14:156-165. doi: 10.1016/j.ncrna.2025.06.002. eCollection 2025 Oct.